Business · 09/05/2013Updated: 10/17/2026 · 1 min read

FDA Releases Draft Guidance on Charging for Investigational Drugs Under IND Applications

The Food and Drug Administration (FDA) has released a draft guidance document titled 'Charging for Investigational Drugs Under an IND--Qs & As' to address questions about its regulation on charging for investigational drugs under an IND application, particularly those made available through expanded access programs.